Improve Clinical Trial Performance and Collaboration with Clinipace Worldwide
We leverage extensive therapeutic knowledge, clinical trial expertise, and innovation to support you in achieving some of your most important goals: Executing regulatory strategies, optimizing clinical development timelines and completing high quality trials.
Clinical Excellence, No Matter the Location
When you’re looking for a clinical research partner, you need someone who understands and appreciates the unique needs of your program—a true partner that can act as an extension of your own team.
We take pride in our expertise in the operational, regulatory, and scientific aspects of your clinical trial. We are guided by the common philosophy that integrating technology with clinical research optimizes project performance while containing costs.
Flexible to Meet Your Needs
While scientific expertise may be the priority in your trial, technology drives your program to the finish line. We use a comprehensive technology platform to support patient enrollment, project management, site selection and management, data capture, data management, monitoring and biostatistics to improve collaboration and data visibility.
Our experts have broad experience and the capabilities you can rely on to combine the right mix of technology and scientific knowledge. That’s the Clinipace difference.
Whether you need support for a single service or the full suite of CRO services, we’ve got you covered
Regulatory and Strategic Development:
“I worked with the Clinipace team in Brazil when I needed to hire quality monitoring services for a Phase IV study in Otolaryngology. The team was very professional during all the project steps. When new staff needed to be incorporated to the study team, the turnaround from Clinipace was very fast and did not compromise the study progress. I would definitely recommend partnership with them for clinical trial monitoring.”
Clinical Quality, Medical Affairs Manager
Fortune 500 Affiliate
“Given the gravity of the disease under study and the significant therapeutic promise shown by PT20 in early research, it was crucial for us to work with a provider that could help us complete this pivotal study quickly and effectively in order to reduce the development risk associated with the PT20 programme. We look forward to working with Clinipace on this important study.”
Julian Howell, Group Medical Director
Phosphate Therapeutics Limited
“I wanted to tell you how pleased I am with the randomization progress since we implemented the leads calling the sites either with subjects approaching day 60 or that had gone beyond day 60. We were averaging 9.7 rands/week in the two months previous to implementation. Not including today, our average has since risen to 12.5/week. A giant thank you to the team is in order. A huge round of congrats and back-patting from the AbbVie team to Clinipace.”
Christa Lee, Clinical Research Manager
“I wanted to let you know that I appreciated the warm welcome during our face-to-face meeting last week. I know a lot of time and effort went into setting this up. You took this study when we were knee deep in and are responsible for the success that we have had with the Pivotal 1 study. We couldn’t have done it without you, and we continue to have success daily with the stellar team that we have been given to work with. You all are a pleasure to work with on a daily basis. You certainly make our jobs easier.”
Julie Gavigan, Contract Sr. CRA,